Healthcare Market Research Reports and Trends

  The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic. At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the  COVID-19 impact on the Embolotherapy Market . We are working diligently to help companies take rapid decisions by studying: The impact of COVID-19 on the Embolotherapy Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market The rapid shifts in the strategies of the Top 50 companies in the Embolotherapy Market The shifting short-term priorities of the top 50 companies’ clients and their client’s clients You can request an in-depth analysis detailing the impact of COVID-19 on the Embolotherapy Market: Let’s fight this crisis together. Speak to Our Analyst to analyse how...

Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth over the forecast period. The  embolotherapy market  is projected to reach  USD 4.9 billion by 2024 from USD 3.3 billion in 2019 , at a  CAGR of 8.1%  from 2019 to 2024. The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario. The embolic agents segment accounted for the largest share of the embolotherapy market, by product, in 2019 Based on product, the embolotherapy market is segmented into embolic agents (embolic coils, em...

Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth Growth in Embolotherapy Market The  global embolotherapy market  is projected to reach $4.9 billion by 2024 from $3.3 billion in 2019, at a  CAGR of 8.1% from 2019 to 2024. The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario. Product of Embolotherapy Market Market is broadly segmented into embolic agents and support devices. The embolic agents segment is further subsegmented into embolic coils, embolic plug syste...

According to the new market research report “ Embolotherapy Market by Product (Embolic Agents (Microspheres, Detachable Coils, Pushable Coils), Guidewires), Disease (Oncology, Aneurysm, Peripheral Vascular), Procedure, End User (Hospitals, Clinics, ASC, Academia ) – Global Forecast to 2024 “, published by MarketsandMarkets ™, the Embolotherapy Market is projected to reach USD 4.9 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 8.1% from 2019 to 2024. ​ Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185897830 ​ The growth of the Embolotherapy Market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario. ​ The embolic agents segment accounted for the largest share of the Embolotherapy Market, by product, in 2019 Based on product, the Embolotherapy Market ...